SAVA Q2 2021 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$115M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$4M

Operating Income

-$5M

Net Income

-$5M

EPS (Diluted)

$-0.13

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$415,000

Balance Sheet

Total Assets

$281M

Total Liabilities

$5M

Stockholders' Equity

$276M

Cash & Equivalents

$278M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$4M	-$591,000	-560.1%
Operating Income	-$5M	-$1M	-341.8%
Net Income	-$5M	-$1M	-351.1%